Actimed Therapeutics

About:

Actimed Therapeutics is a clinical stage biopharmaceutical company.

Website: https://actimedtherapeutics.com/

Top Investors: Mankind Pharma

Description:

Actimed Therapeutics is a clinical stage biopharmaceutical company focused on bringing innovation to the treatment of muscle wasting disorders to transform the care of an underserved and vulnerable patient population. The company produces anabolic/catabolic transforming agents to treat cachexia, an often deadly syndrome linked with a wide range of chronic illnesses, allowing healthcare providers to manage cancer-related cachexia. Actimed was founded in 2017 by Stefan Anker and Andrew Coats in Ascot, Windsor and Maidenhead.

Total Funding Amount:

23.5M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ascot, Windsor and Maidenhead, United Kingdom

Founded Date:

2017-01-01

Contact Email:

info(AT)actimedtherapeutics.com

Founders:

Andrew Coats, Stefan D. Anker

Number of Employees:

1-10

Last Funding Date:

2023-08-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai